Fresenius Medical Care AAQS 2024
Fresenius Medical Care AAQS
Fresenius Medical Care Yield Dividen
Ticker
ISIN
WKN
Fresenius Medical Care memiliki AAQS saat ini sebesar 3. AAQS yang tinggi dapat dianggap sebagai indikasi positif bahwa perusahaan berkembang dengan sukses. Investor dapat mengasumsikan bahwa perusahaan sedang dalam jalur yang baik untuk meraih keuntungan. Di sisi lain, penting untuk membandingkan AAQS dari saham Fresenius Medical Care dengan keuntungan yang diperoleh dan perusahaan lain dalam industri yang sama. AAQS yang tinggi bukanlah jaminan mutlak untuk masa depan yang positif. Hanya dengan cara itu kita dapat mendapatkan gambaran lengkap mengenai kinerja perusahaan. Untuk dapat lebih baik menilai perkembangan perusahaan, penting untuk melihat AAQS dibandingkan dengan perusahaan lain dalam industri yang sama. Secara umum, investor harus selalu mempertimbangkan AAQS sebuah perusahaan dalam kaitannya dengan metrik lain seperti keuntungan, EBIT, arus kas, dan lainnya untuk membuat keputusan investasi yang berdasar.
Fresenius Medical Care Aktienanalyse
Apa yang dilakukan Fresenius Medical Care?
Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.Fresenius Medical Care Pendapatan per Segmen
Dalam laporan tahunan saham Fresenius Medical Care (DE0005785802, 578580, FME.DE), ia membagi pendapatannya dalam 4 segmen: 1. North America, 2. EMEA, 3. Asia-Pacific, 4. Latin America. Saham Fresenius Medical Care (WKN: 578580, ISIN: DE0005785802, Ticker-Symbol: FME.DE) adalah investasi terkemuka untuk investor yang tertarik dalam partisipasi di sektor Health Care.
Pertanyaan Umum tentang Saham Fresenius Medical Care
Saham Fresenius Medical Care dapat dijadikan rencana tabungan di penyedia layanan berikut: Trade Republic, ING, Scalable Capital dan Consorsbank
Andere Kennzahlen von Fresenius Medical Care
Analisis saham kami untuk saham Fresenius Medical Care Pendapatan mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (KGV), P/S ratio (KUV), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Fresenius Medical Care Pendapatan. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.
- Fresenius Medical Care Pendapatan
- Fresenius Medical Care Keuntungan
- Fresenius Medical Care PER
- Fresenius Medical Care KUV
- Fresenius Medical Care EBIT
- Fresenius Medical Care Dividen
- Fresenius Medical Care Saham
- Fresenius Medical Care Kapitalisasi Pasar
- Fresenius Medical Care Utang
- Fresenius Medical Care Utang
- Fresenius Medical Care Modal sendiri
- Fresenius Medical Care AAQS
- Fresenius Medical Care Karyawan
- Fresenius Medical Care ROE
- Fresenius Medical Care ROA
- Fresenius Medical Care ROCE